Label: ISNTREE HYALURONIC ACID DAILY SUNGEL- avobenzone, homosalate, octisalate cream

  • NDC Code(s): 81100-501-01, 81100-501-02
  • Packager: ISNTREE Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated April 3, 2024

If you are a consumer or patient please visit this version.

  • Active ingredients

    Avobenzone 2.7 %
    Homosalate 9 %
    Octisalate 4.5 %

  • Purpose

    sunscreen

  • Uses


    • helps prevent sunburn • higher SPF gives more sunburn protection
    • if used as directed with other sun protection measures (see Directions)
    decreases the risk of skin cancer and early skin aging caused by the sun

  • Warnings

    For external use only.

  • Do not use


    • on damaged skin or broken skin.

  • When using this product

    • keep out of eyes. Rinse with water to remove.

  • Stop use and ask a doctor if

    •rash or irritation develops and lasts.

  • Keep out of reach of children


    If swallowed, get medical help or contact
    a Poison Control Center right away.

  • Directions


    ■ apply liberally 15 minutes before sun exposure.
    Sun Protection Measures. Spending time in the sun increases your risk of
    skin cancer and early skin aging. To decrease this risk, regularly use a
    sunscreen with a Broad Spectrum SPF value of 15 or higher and other
    sun protection measures including:
    • limit time in the sun, especially from 10 a.m. - 2 p.m.
    • wear long-sleeved shirts, pants, hats, and sunglasses
    ■ children under 6 months of age: Ask a doctor
    ■ reapply at least every 2 hours.
    ■ use a water-resistant sunscreen if swimming or sweating.

  • Other information


    ■ protect the product from exessive heat and
    direct sun ■ Sun alert: Limiting sun exposure, wearing protective clothing, and
    using sunscreens may reduce the risks of skin aging, skin cancer, and other
    harmful effects of the sun.

  • Inactive ingredients

    Water, Butyloctyl Salicylate, Butylene Glycol, Diethylhexyl 2,6-Naphthalate, Niacinamide, C20-22 Alkyl Phosphate, C20-22 Alcohols, 1,2-Hexanediol, Pentylene Glycol, Acrylates Copolymer, Polymethylsilsesquioxane, Cetyl Alcohol, Poly C10-30 Alkyl Acrylate, VP/Eicosene Copolymer, Glyceryl Stearate, Silica, Tromethamine, Propanediol, Polyacrylate Crosspolymer-6, Xanthan Gum, Ethylhexylglycerin, Adenosine, Portulaca Oleracea Extract, Centella Asiatica Extract, Houttuynia Cordata Extract, Hydrolyzed Hyaluronic Acid, Hydrolyzed Sodium Hyaluronate, Dimethylsilanol Hyaluronate, Hyaluronic Acid, Sodium Hyaluronate, Potassium Hyaluronate, Sodium Hyaluronate Crosspolymer, Hydroxypropyltrimonium Hyaluronate, Sodium Hyaluronate Dimethylsilanol, Sodium Acetylated Hyaluronate, Tocopherol, Ectoin, Dipropylene Glycol, Sodium Palmitoyl Proline, Glycerin, Beta-Glucan, Nymphaea Alba Flower Extract

  • PRINCIPAL DISPLAY PANEL

    ISNTREE HYALURONIC ACID DAILY SUN GEL

  • INGREDIENTS AND APPEARANCE
    ISNTREE HYALURONIC ACID DAILY SUNGEL 
    avobenzone, homosalate, octisalate cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:81100-501
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE4.5 g  in 50 mL
    AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE1.35 g  in 50 mL
    OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE2.25 g  in 50 mL
    Inactive Ingredients
    Ingredient NameStrength
    POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    ADENOSINE (UNII: K72T3FS567)  
    DIETHYLHEXYL 2,6-NAPHTHALATE (UNII: I0DQJ7YGXM)  
    NIACINAMIDE (UNII: 25X51I8RD4)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    PROPANEDIOL (UNII: 5965N8W85T)  
    HYALURONIC ACID (UNII: S270N0TRQY)  
    SODIUM PALMITOYL PROLINE (UNII: 64L053FRFO)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    DIMETHYLSILANOL HYALURONATE (UNII: Z853O1D4TE)  
    HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
    C20-22 ALCOHOLS (UNII: O4M0347C6A)  
    TOCOPHEROL (UNII: R0ZB2556P8)  
    DIPROPYLENE GLYCOL (UNII: E107L85C40)  
    PENTYLENE GLYCOL (UNII: 50C1307PZG)  
    TROMETHAMINE (UNII: 023C2WHX2V)  
    CENTELLA ASIATICA TRITERPENOIDS (UNII: 4YS74Q4G4J)  
    HOUTTUYNIA CORDATA FLOWERING TOP (UNII: RH041UUZ22)  
    PURSLANE (UNII: M6S840WXG5)  
    ECTOINE (UNII: 7GXZ3858RY)  
    WATER (UNII: 059QF0KO0R)  
    GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
    AMMONIUM ACRYLOYLDIMETHYLTAURATE, DIMETHYLACRYLAMIDE, LAURYL METHACRYLATE AND LAURETH-4 METHACRYLATE COPOLYMER, TRIMETHYLOLPROPANE TRIACRYLATE CROSSLINKED (45000 MPA.S) (UNII: Q7UI015FF9)  
    NYMPHAEA ALBA FLOWER (UNII: 40KQ7Q535O)  
    BUTYLOCTYL SALICYLATE (UNII: 2EH13UN8D3)  
    C20-22 ALKYL PHOSPHATE (UNII: L4VKP0Y7RP)  
    1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:81100-501-021 in 1 BOX01/17/2024
    1NDC:81100-501-0150 mL in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02001/17/2024
    Labeler - ISNTREE Inc. (689043012)
    Establishment
    NameAddressID/FEIBusiness Operations
    Kolmar Korea Co.,LTD. Gwanjeong 2 factory963271750manufacture(81100-501)